Tremlett H - Search Results

1

Long-term persistence with the immunomodulatory drugs for multiple sclerosis: a retrospective database study.

Evans C, Tam J, Kingwell E, Oger J; University of British Columbia MS Clinic Neurologists; Tremlett H. Evans C, et al. Among authors: tremlett h. Clin Ther. 2012 Feb;34(2):341-50. doi: 10.1016/j.clinthera.2012.01.006. Epub 2012 Jan 31. Clin Ther. 2012. PMID: 22296946

2

Prescribing for multiple sclerosis patients in general practice: a case-control study.

Tremlett HL, Luscombe DK, Wiles CM. Tremlett HL, et al. J Clin Pharm Ther. 2001 Dec;26(6):437-44. doi: 10.1046/j.1365-2710.2001.00377.x. J Clin Pharm Ther. 2001. PMID: 11722681

3

Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS.

Tremlett HL, Oger J. Tremlett HL, et al. Neurology. 2003 Aug 26;61(4):551-4. doi: 10.1212/01.wnl.0000078885.05053.7d. Neurology. 2003. PMID: 12939437 Review.

4

Liver injury associated with the beta-interferons for MS: a comparison between the three products.

Tremlett HL, Yoshida EM, Oger J. Tremlett HL, et al. Neurology. 2004 Feb 24;62(4):628-31. doi: 10.1212/wnl.62.4.628. Neurology. 2004. PMID: 14981183 Review.

5

Elevated aminotransferases during treatment with interferon-beta for multiple sclerosis: actions and outcomes.

Tremlett HL, Oger J. Tremlett HL, et al. Mult Scler. 2004 Jun;10(3):298-301. doi: 10.1191/1352458504ms1007oa. Mult Scler. 2004. PMID: 15222695

6

Hepatic injury, liver monitoring and the beta-interferons for multiple sclerosis.

Tremlett H, Oger J. Tremlett H, et al. J Neurol. 2004 Nov;251(11):1297-303. doi: 10.1007/s00415-004-0619-5. J Neurol. 2004. PMID: 15592724 Review.

7

Disability progression in multiple sclerosis is slower than previously reported.

Tremlett H, Paty D, Devonshire V. Tremlett H, et al. Neurology. 2006 Jan 24;66(2):172-7. doi: 10.1212/01.wnl.0000194259.90286.fe. Neurology. 2006. PMID: 16434648

8

Does the season or month of birth influence disease progression in multiple sclerosis?

Tremlett HL, Devonshire VA. Tremlett HL, et al. Neuroepidemiology. 2006;26(4):195-8. doi: 10.1159/000092406. Epub 2006 Mar 28. Neuroepidemiology. 2006. PMID: 16567947

9

Is late-onset multiple sclerosis associated with a worse outcome?

Tremlett H, Devonshire V. Tremlett H, et al. Neurology. 2006 Sep 26;67(6):954-9. doi: 10.1212/01.wnl.0000237475.01655.9d. Neurology. 2006. PMID: 17000960

10

Liver test abnormalities in multiple sclerosis: findings from placebo-treated patients.

Tremlett H, Seemüller S, Zhao Y, Yoshida EM, Oger JD, Petkau J. Tremlett H, et al. Neurology. 2006 Oct 10;67(7):1291-3. doi: 10.1212/01.wnl.0000238515.27055.62. Neurology. 2006. PMID: 17030771 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters